Intensive Lifestyle Interventions to Overweight and Obese Patients in Primary Care
The Effect of Intensive Lifestyle Intervention Applied to Overweight and Obese Patients in Primary Care During the Pandemic Period: a Randomised Controlled Trial
1 other identifier
observational
165
1 country
1
Brief Summary
The goal of this clinical trial is to compare in the effect of different lifestyle interventions in overweight and obese participants. The main questions it aims to answer are:
- effect on anthropometric measurements
- effect on lipid profile
- effect on weight-related quality of life
- observe the differences between interventions The study participants were stratified into three groups: intervention, control-1, and control-2.
- Intervention group: They were given a calorie-restricted diet and exercise plan by a dietician or physiotherapist at their first visit, and were followed up by telephone calls at weeks 2, 4, 6, 8 and 10 over 12 weeks.
- Control-1 group: During the initial medical interview, the participants were given a calorie-restricted diet programme by a dietician and an exercise programme by a physiotherapist; they were followed up over 12 weeks with telephone calls at week 4.
- Control-2 group: The participants were not provided with any programme, and the importance of weight loss was emphasised by the family physicians. Dietary and physical activity advice was given according to the recommendations in the Turkish Endocrine and Metabolism Association 2019 Obesity Diagnosis and Treatment Guide, and was followed up with phone calls at weeks 2, 4, 6, 8 and 10 over a 12-weeks.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 25, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2022
CompletedFirst Submitted
Initial submission to the registry
March 4, 2024
CompletedFirst Posted
Study publicly available on registry
March 20, 2024
CompletedResults Posted
Study results publicly available
February 4, 2025
CompletedFebruary 4, 2025
January 1, 2025
8 months
March 4, 2024
March 21, 2024
January 11, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Primary Outcome
Turkish version of the Impact of Weight on Quality of Life-Lite Version (IWQOL) scale was used. The scale has a minimum score of 0 and a maximum of 100. The scoring system is valid for both the scale subgroups and the scale total score. Based on the scale scoring, quality-of-life decreases as the score decreases.
3 months
Secondary Outcomes (4)
Secondary
3 months
BMI (kg/m2)
3 months
Waist Circumference (cm)
3 months
Lipid Profile
3 months
Study Arms (3)
Intervention group
They were given a calorie-restricted diet and exercise plan by a dietician or physiotherapist at their first visit, and were followed up by telephone calls at weeks 2, 4, 6, 8 and 10 over 12 weeks.
Control-1 group
During the initial medical interview, the participants were given a calorie-restricted diet programme by a dietician and an exercise programme by a physiotherapist; they were followed up over 12 weeks with telephone calls at week 4.
Control-2 group
The participants were not provided with any programme, and the importance of weight loss was emphasised by the family physicians. Dietary and physical activity advice was given according to the recommendations in the Turkish Endocrine and Metabolism Association 2019 Obesity Diagnosis and Treatment Guide, and was followed up with phone calls at weeks 2, 4, 6, 8 and 10 over a 12-weeks.
Interventions
Eligibility Criteria
The study\'s participants comprised of overweight and obese individuals who made applications to the Department of Family Medicine at XXX University\'s Faculty of Medicine. Detailed information regarding the study was provided to overweight and obese individuals who applied between the dates of 25th January 2022 and 31st October 2022 and consented to participate in said study.
You may qualify if:
- Age 18-40 BMI ≥ 25 kg/m 2 Agreeing to participate in the study Not having a diagnosed chronic disease To be able to ambulate To be cooperative
You may not qualify if:
- Receiving medical treatment
- Secondary obesity (hypothyroidism, Cushing\'s disease, etc.)
- Chronic disease (cardiovascular diseases, pulmonary diseases, presence of diabetes mellitus, liver diseases, renal diseases)
- Having hyperlipidaemia under treatment
- Cancer
- Pregnancy or breastfeeding
- Psychiatric disorder
- Orthopaedic or neurological disease that may prevent walking
- Are currently taking weight loss medication or enrolled in another weight loss program
- Having previously undergone obesity surgery or having surgery planned during the study period
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duygu Ayhan Baserlead
- Hacettepe Universitycollaborator
Study Sites (1)
Hacettepe University
Ankara, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
Yet, the three-month follow-up might not sufficiently capture lifestyle intervention impacts. Challenges in reaching participants during telephone follow-ups led to exclusions, potentially influencing the study's completeness.
Results Point of Contact
- Title
- Assoc.Prof. Duygu Ayhan Baser
- Organization
- Hacettepe University
Study Officials
- STUDY DIRECTOR
Duygu Ayhan Baser, Assoc. Prof.
Hacettepe University
- PRINCIPAL INVESTIGATOR
Dilara Canbay Ozdemir, M.D.
Hacettepe University
- PRINCIPAL INVESTIGATOR
İzzet Fidanci, Assoc. Prof.
Hacettepe University
- PRINCIPAL INVESTIGATOR
Arzu Demircioglu Karagoz
Hacettepe University
- PRINCIPAL INVESTIGATOR
Merve Ozdemir
Afyonkarahisar Health Sciences University
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- observational
- Observational Model
- CASE CROSSOVER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Assoc Prof
Study Record Dates
First Submitted
March 4, 2024
First Posted
March 20, 2024
Study Start
January 25, 2022
Primary Completion
October 1, 2022
Study Completion
December 1, 2022
Last Updated
February 4, 2025
Results First Posted
February 4, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share